Biliary Tract Neoplasms Active Not Recruiting Phase 2 Trials for Durvalumab (DB11714)

Also known as: Biliary Tract Neoplasm / Neoplasm biliary tract / Biliary neoplasm NOS / Biliary neoplasm / Neoplasm of biliary tract (disorder) / Biliary neoplasia

IndicationStatusPhase
DBCOND0032430 (Biliary Tract Neoplasms)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03046862Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract CancerTreatment
NCT04308174Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract CancerTreatment